Rifaximin Improves Spatial Learning and Memory Impairment in Rats with Liver Damage-Associated Neuroinflammation
Patients with non-alcoholic fatty liver disease (NAFLD) may show mild cognitive impairment. Neuroinflammation in the hippocampus mediates cognitive impairment in rat models of minimal hepatic encephalopathy (MHE). Treatment with rifaximin reverses cognitive impairment in a large proportion of cirrho...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219896/ https://www.ncbi.nlm.nih.gov/pubmed/35740285 http://dx.doi.org/10.3390/biomedicines10061263 |
_version_ | 1784732235224580096 |
---|---|
author | Leone, Paola Mincheva, Gergana Balzano, Tiziano Malaguarnera, Michele Felipo, Vicente Llansola, Marta |
author_facet | Leone, Paola Mincheva, Gergana Balzano, Tiziano Malaguarnera, Michele Felipo, Vicente Llansola, Marta |
author_sort | Leone, Paola |
collection | PubMed |
description | Patients with non-alcoholic fatty liver disease (NAFLD) may show mild cognitive impairment. Neuroinflammation in the hippocampus mediates cognitive impairment in rat models of minimal hepatic encephalopathy (MHE). Treatment with rifaximin reverses cognitive impairment in a large proportion of cirrhotic patients with MHE. However, the underlying mechanisms remain unclear. The aims of this work were to assess if rats with mild liver damage, as a model of NAFLD, show neuroinflammation in the hippocampus and impaired cognitive function, if treatment with rifaximin reverses it, and to study the underlying mechanisms. Mild liver damage was induced with carbon-tetrachloride. Infiltration of immune cells, glial activation, and cytokine expression, as well as glutamate receptors expression in the hippocampus and cognitive function were assessed. We assessed the effects of daily treatment with rifaximin on the alterations showed by these rats. Rats with mild liver damage showed hippocampal neuroinflammation, reduced membrane expression of glutamate N-methyl-D-aspartate (NMDA) receptor subunits, and impaired spatial memory. Increased C-C Motif Chemokine Ligand 2 (CCL2), infiltration of monocytes, microglia activation, and increased tumor necrosis factor α (TNFα) were reversed by rifaximin, that normalized NMDA receptor expression and improved spatial memory. Thus, rifaximin reduces neuroinflammation and improves cognitive function in rats with mild liver damage, being a promising therapy for patients with NAFLD showing mild cognitive impairment. |
format | Online Article Text |
id | pubmed-9219896 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92198962022-06-24 Rifaximin Improves Spatial Learning and Memory Impairment in Rats with Liver Damage-Associated Neuroinflammation Leone, Paola Mincheva, Gergana Balzano, Tiziano Malaguarnera, Michele Felipo, Vicente Llansola, Marta Biomedicines Article Patients with non-alcoholic fatty liver disease (NAFLD) may show mild cognitive impairment. Neuroinflammation in the hippocampus mediates cognitive impairment in rat models of minimal hepatic encephalopathy (MHE). Treatment with rifaximin reverses cognitive impairment in a large proportion of cirrhotic patients with MHE. However, the underlying mechanisms remain unclear. The aims of this work were to assess if rats with mild liver damage, as a model of NAFLD, show neuroinflammation in the hippocampus and impaired cognitive function, if treatment with rifaximin reverses it, and to study the underlying mechanisms. Mild liver damage was induced with carbon-tetrachloride. Infiltration of immune cells, glial activation, and cytokine expression, as well as glutamate receptors expression in the hippocampus and cognitive function were assessed. We assessed the effects of daily treatment with rifaximin on the alterations showed by these rats. Rats with mild liver damage showed hippocampal neuroinflammation, reduced membrane expression of glutamate N-methyl-D-aspartate (NMDA) receptor subunits, and impaired spatial memory. Increased C-C Motif Chemokine Ligand 2 (CCL2), infiltration of monocytes, microglia activation, and increased tumor necrosis factor α (TNFα) were reversed by rifaximin, that normalized NMDA receptor expression and improved spatial memory. Thus, rifaximin reduces neuroinflammation and improves cognitive function in rats with mild liver damage, being a promising therapy for patients with NAFLD showing mild cognitive impairment. MDPI 2022-05-28 /pmc/articles/PMC9219896/ /pubmed/35740285 http://dx.doi.org/10.3390/biomedicines10061263 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Leone, Paola Mincheva, Gergana Balzano, Tiziano Malaguarnera, Michele Felipo, Vicente Llansola, Marta Rifaximin Improves Spatial Learning and Memory Impairment in Rats with Liver Damage-Associated Neuroinflammation |
title | Rifaximin Improves Spatial Learning and Memory Impairment in Rats with Liver Damage-Associated Neuroinflammation |
title_full | Rifaximin Improves Spatial Learning and Memory Impairment in Rats with Liver Damage-Associated Neuroinflammation |
title_fullStr | Rifaximin Improves Spatial Learning and Memory Impairment in Rats with Liver Damage-Associated Neuroinflammation |
title_full_unstemmed | Rifaximin Improves Spatial Learning and Memory Impairment in Rats with Liver Damage-Associated Neuroinflammation |
title_short | Rifaximin Improves Spatial Learning and Memory Impairment in Rats with Liver Damage-Associated Neuroinflammation |
title_sort | rifaximin improves spatial learning and memory impairment in rats with liver damage-associated neuroinflammation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219896/ https://www.ncbi.nlm.nih.gov/pubmed/35740285 http://dx.doi.org/10.3390/biomedicines10061263 |
work_keys_str_mv | AT leonepaola rifaximinimprovesspatiallearningandmemoryimpairmentinratswithliverdamageassociatedneuroinflammation AT minchevagergana rifaximinimprovesspatiallearningandmemoryimpairmentinratswithliverdamageassociatedneuroinflammation AT balzanotiziano rifaximinimprovesspatiallearningandmemoryimpairmentinratswithliverdamageassociatedneuroinflammation AT malaguarneramichele rifaximinimprovesspatiallearningandmemoryimpairmentinratswithliverdamageassociatedneuroinflammation AT felipovicente rifaximinimprovesspatiallearningandmemoryimpairmentinratswithliverdamageassociatedneuroinflammation AT llansolamarta rifaximinimprovesspatiallearningandmemoryimpairmentinratswithliverdamageassociatedneuroinflammation |